1. Outcomes of beta blocker use in advanced hepatocellular carcinoma treated with immune checkpoint inhibitors
   Y. Linda Wu et al, 2023, Frontiers in Oncology CrossRef
2. Non-selective beta-blockers and the incidence of hepatocellular carcinoma in patients with cirrhosis: a meta-analysis
   Xinyi He et al, 2023, Frontiers in Pharmacology CrossRef
3. β-Adrenergic modulation of cancer cell proliferation: available evidence and clinical perspectives
   Marisa Coelho et al, 2017, Journal of Cancer Research and Clinical Oncology CrossRef
4. Drug Repurposing in Gastric Cancer: Current Status and Future Perspectives
   Marina Leite et al, 2023, Hereditary Gastric and Breast Cancer Syndrome CrossRef
5. β-blockers in advanced cirrhosis: More friend than enemy
   Ki Tae Yoon et al, 2021, Clinical and Molecular Hepatology CrossRef
6. Therapeutic Targeting of Cancer Stem Cells via Modulation of the Renin-Angiotensin System
   Imogen M. Roth et al, 2019, Frontiers in Oncology CrossRef
7. The Potent Cytotoxic and Oxidative Effects of β-2 Selective ICI-118,551 on Breast Adenocarcinoma Cell Lines with Different Aggressiveness
   Berna KAVAKCIOĞLU YARDIMCI, 2021, Clinical and Experimental Health Sciences CrossRef
8. Nicotinamide N-Methyltransferase Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric Cancer
   Miaowei Wu et al, 2020, Frontiers in Genetics CrossRef
9. Propranolol Is Associated with Lower Risk of Incidence of Hepatocellular Carcinoma in Patients with Alcoholic Cirrhosis: A Tertiary-Center Study and Indirect Comparison with Meta-Analysis
   Tzu-Hao Li et al, 2020, Gastroenterology Research and Practice CrossRef
10. Trial watch: beta-blockers in cancer therapy
    Killian Carnet Le Provost et al, 2023, OncoImmunology CrossRef
11. Effect of Propranolol Treatment on the Incidence of Hepatocellular Carcinoma in Patients Waiting for Liver Transplant With Cirrhosis: A Retrospective, Surveillance Study in a Tertiary Center
    Nuretdin Suna et al, 2019, Experimental and Clinical Transplantation CrossRef
12. β-Adrenergic Receptor Inhibitor and Oncolytic Herpesvirus Combination Therapy Shows Enhanced Antitumoral and Antiangiogenic Effects on Colorectal Cancer
    Jiali Hu et al, 2021, Frontiers in Pharmacology CrossRef
13. The role of ADRB2 gene polymorphisms in malignancies
    Yaqian Wang et al, 2021, Molecular Biology Reports CrossRef
14. Harnessing interventions during the immediate perioperative period to improve the long-term survival of patients following radical gastrectomy
    Lin-Bo Liu et al, 2023, World Journal of Gastrointestinal Surgery CrossRef